Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fulvestrant + Anastrozole vs Anastrozole in Advanced Breast Cancer
NCT02140437Phase 2Withdrawn
- Sponsor
- Fudan University
- Start
- Mar 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of fulvestrant in breast cancer, sponsored by Fudan University. Planned start Mar 2014; status: withdrawn.
02
Drugs
fulvestrant
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02140437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02140437.